Visualizar Tese - Instituto de Biociências - Unesp

Visualizar Tese - Instituto de Biociências - Unesp Visualizar Tese - Instituto de Biociências - Unesp

10.07.2015 Views

Cirilo, PDRREFERÊNCIAS231Watanabe Y and Maekawa M. Methylation of DNA in cancer. Adv Clin Chem, 52, 145-167, 2010.Waugh DJ and Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res, 14, 6735-6741,2008.Wei LH, Torng PL, Hsiao SM et al. Histone Deacetylase 6 Regulates Estrogen Receptor {alpha} inUterine Leiomyoma. Reprod Sci, Epub ahead of print, 2011.Weston G, Trajstman AC, Gargett CE et al. Fibroids display an anti-angiogenic gene expressionprofile when compared with adjacent myometrium. Mol Hum Reprod, 9, 541–549, 2003.Wheeler DA, Srinivasan M, Egholm M et al. The complete genome of an individual by massivelyparallel DNA sequencing. Nature, 452, 872-876, 2008.WHO Consultation on obesity. Geneva: World Health Organ, 1997.Williams AJ, Powell WL, Collins, T et al. HMGI(Y) expression in human uterine leiomyomata.Involvement of another high-mobility group architectural factor in a benign neoplasm. Am JPathol, 150, 911-918, 1997.Wolverton T and Lalande M. Identification and characterization of three members of a novelsubclass of protocadherins. Genomics, 66-72, 2001.Wong KK, de Leeuw RJ, Dosanjh NS et al: A comprehensive analysis of common copy-numbervariations in the human genome. Am J Hum Genet, 80, 91–104, 2007.Wu CL, Classon M, Dyson N et al. Expression of dominant-negative mutant DP-1 blocks cell cycleprogression in G1. Mol Cell Biol, 16, 3698-3706, 1996.Wu T, Chen X, Xie L. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.Cochrane Database Syst Rev, 17, CD005287, 2007.Wu X, Blanck A, Olovsson M et al. Expression of basic fibroblast growth factor (bFGF), FGF receptor1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle,after menopause and GnRHa treatment. Acta Obstet Gynecol Scand, 80, 497-504, 2001.Xiao HL, Eyden B, Yan XC et al. Intraparenchymal myofibromatosis of the brain in an adult: report ofan unusual case. Neuropathology, 30, 288-293, 2010.Xiao J, Liu CC, Chen PL et al. RINT-1, a novel Rad50-interacting protein, participates in radiationinducedG(2)/M checkpoint control. J Biol Chem, 276, 6105-6111 2001.Xie Y, Yang D, He Q et al. Zebrafish as a model system to study the physiological function oftelomeric protein TPP1. PLoS One, 6, e16440, 2011.Xing YP, Powell WL, Morton CC. The del(7) subgroup in Uterine Leiomyomata: genetic and biologiccharacteristics. Cancer Genet Cytogenet, 98, 69-74, 1997.Xu Q, Takekida S, Ohara N et al. Progesterone receptor modulator CDB-2914 down-regulatesproliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3

Cirilo, PDRREFERÊNCIAS232and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured humanuterine leiomyoma cells. J Clin Endocrinol Metab, 90, 953-961, 2005.Xu Y, Jing Y, Ma S et al. Primary angioleiomyoma in the sellar region: a case report and literaturereview. Clin Neuropathol, 29, 21-25, 2010.Yen-Ping HJ, Man WC, Wen Y et al. Transforming growth interacting factor expression in leiomyomacompared with myometrium. Fertil Steril, 94, 1078-1083, 2010.Ying J, Li H, Seng TJ et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidatetumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas withfrequent methylation. Oncogene, 25, 1070-1080, 2006.Yoshida S, Ohara N, Xu Q et al. Cell-type specific actions of progesterone receptor modulators in theregulation of uterine leiomyoma growth. Semin Reprod Med, 28, 260-273, 2010.Young A. Receptor pharmacology. Adv Pharmacol, 52, 47-65, 2005.Yu H and Rohan T. Role of the insulin-like growth factor family in cancer development andprogression. J Natl Cancer Inst, 92, 1472–1489, 2000.Yu W, Kanaan Y, Bae YK et al. Chromosomal changes in aggressive breast cancers with basal-likefeatures. Cancer Genet Cytogenet, 193, 29–37, 2009.Zaitseva M, Vollenhoven BJ, Rogers PAW. In vitro culture significantly alters gene expressionprofiles and reduces differences between myometrial and fibroid smooth muscle cells. MolHum Reprod, 12, 187–207, 2006.Zaloudek CJ and Norris HJ. Mesenchymal tumors of the uterus. In: Fenoglio CM, Wolff M, eds. ProgSurg Pathol 3th ed. New York: Masson, 35pp, 1981.Zasławski R, Surowiak P, Dziegiel P et al. Analysis of the expression of estrogen and progesteronreceptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relationto the phase of the menstrual cycle. Med Sci Monit, 7, 908-913, 2001.Zavadil J, Ye H, Liu Z et al. Profiling and Functional Analyses of MicroRNAs and Their Target GeneProducts in Human Uterine Leiomyomas. PLoS ONE, 5, e12362, 2010.Zeng WR, Scherer SW, Koutsilieris M et al. Loss of heterozygosity and reduced expression of theCUTL1 gene in uterine leiomyomas. Oncogene, 14, 2355-2365, 1997.Zhang XY, Shi L, Liu Y et al. ICPS: an integrative cancer profiler system. Bioinformatics, 26, 2649-2650, 2010.Zheng HC, Wei ZL, Xu XY et al. Parafibromin expression is an independent prognostic factor forcolorectal carcinomas. Hum Pathol, Epub ahead of print, 2011.Zydan HLS, Fagundes DJ, Sória-Vieira S et al. Hysterectomy and benign gynecological diseases: whathas been performed in Medical Residency in Brazil? Rev Bras Ginecol Obstet, 29, 67-73,2007.

Cirilo, PDRREFERÊNCIAS231Watanabe Y and Maekawa M. Methylation of DNA in cancer. Adv Clin Chem, 52, 145-167, 2010.Waugh DJ and Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res, 14, 6735-6741,2008.Wei LH, Torng PL, Hsiao SM et al. Histone Deacetylase 6 Regulates Estrogen Receptor {alpha} inUterine Leiomyoma. Reprod Sci, Epub ahead of print, 2011.Weston G, Trajstman AC, Gargett CE et al. Fibroids display an anti-angiogenic gene expressionprofile when compared with adjacent myometrium. Mol Hum Reprod, 9, 541–549, 2003.Wheeler DA, Srinivasan M, Egholm M et al. The complete genome of an individual by massivelyparallel DNA sequencing. Nature, 452, 872-876, 2008.WHO Consultation on obesity. Geneva: World Health Organ, 1997.Williams AJ, Powell WL, Collins, T et al. HMGI(Y) expression in human uterine leiomyomata.Involvement of another high-mobility group architectural factor in a benign neoplasm. Am JPathol, 150, 911-918, 1997.Wolverton T and Lalan<strong>de</strong> M. I<strong>de</strong>ntification and characterization of three members of a novelsubclass of protocadherins. Genomics, 66-72, 2001.Wong KK, <strong>de</strong> Leeuw RJ, Dosanjh NS et al: A comprehensive analysis of common copy-numbervariations in the human genome. Am J Hum Genet, 80, 91–104, 2007.Wu CL, Classon M, Dyson N et al. Expression of dominant-negative mutant DP-1 blocks cell cycleprogression in G1. Mol Cell Biol, 16, 3698-3706, 1996.Wu T, Chen X, Xie L. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.Cochrane Database Syst Rev, 17, CD005287, 2007.Wu X, Blanck A, Olovsson M et al. Expression of basic fibroblast growth factor (bFGF), FGF receptor1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle,after menopause and GnRHa treatment. Acta Obstet Gynecol Scand, 80, 497-504, 2001.Xiao HL, Ey<strong>de</strong>n B, Yan XC et al. Intraparenchymal myofibromatosis of the brain in an adult: report ofan unusual case. Neuropathology, 30, 288-293, 2010.Xiao J, Liu CC, Chen PL et al. RINT-1, a novel Rad50-interacting protein, participates in radiationinducedG(2)/M checkpoint control. J Biol Chem, 276, 6105-6111 2001.Xie Y, Yang D, He Q et al. Zebrafish as a mo<strong>de</strong>l system to study the physiological function oftelomeric protein TPP1. PLoS One, 6, e16440, 2011.Xing YP, Powell WL, Morton CC. The <strong>de</strong>l(7) subgroup in Uterine Leiomyomata: genetic and biologiccharacteristics. Cancer Genet Cytogenet, 98, 69-74, 1997.Xu Q, Takekida S, Ohara N et al. Progesterone receptor modulator CDB-2914 down-regulatesproliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!